retatrutide weight loss retatrutide clinical trial results The result of the late stage is another boost to Eli Lilly's booming obesity business — weight-loss drugs have helped propel the US company to become the first pharmaceuticals group to Peptide Series #3 — Retatrutide

Unlike drugs, the skills you build keep working after treatment ends

This promotion was updated December 2025

Light GA, Braff DL (2005a)

Note: Liraglutides weight-loss version, Saxenda [archived link], is still brand-only

It adds to the growing body of evidence suggesting that GLP-1 receptor agonists may have neuroprotective properties, which could benefit patients beyond glucose control. However, as a clinician, Im also aware of the need for further research, including longer-term studies and randomized controlled trials, to better understand the mechanisms and validate these findings before making changes to my treatment approach, she added

While some may experience changes within weeks, others may require more time